• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[生脉姜黄散对鼻咽癌放射抗拒细胞裸鼠肠道菌群的影响]

[Effects of Shengmai Jianghuang San on intestinal flora in nude mice with radio resistant cells of nasopharyngeal carcinoma].

作者信息

Yang Jia-Bin, Zhu Dao-Qi, Shao Meng, Li Ai-Wu, Liu Zhao-Ru, Gao Rui-Jiao, Liu Shi-Ya, Lou Dan-Dan, Lyu Ying, Fan Qin

机构信息

School of Traditional Chinese Medicine,Southern Medical University Guangzhou 510515,China.

Nanfang Hospital,Southern Medical University Guangzhou 510515,China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(3):553-558. doi: 10.19540/j.cnki.cjcmm.20181203.001.

DOI:10.19540/j.cnki.cjcmm.20181203.001
PMID:30989922
Abstract

Modern pharmacological studies have shown that Shengmai San has the effects of enhancing immunity and improving blood circulation, and Curcumae Longae Rhizoma(Jianghuang) has anti-inflammatory, anti-cancer, anti-oxidation and other functions. Shengmai San combined with Jianghuang is a new research direction in the study of anti-tumor of traditional Chinese medicines. The main treatment for nasopharyngeal carcinoma is radiation therapy, but radiation therapy can cause a variety of side effects, and it also changes the composition of the intestinal flora. In this study, the 16 s rDNA sequencing platform was used to perform macro-sequence sequencing of the intestinal flora samples of nude mice bearing the veins of Shengmai Jianghuang San, and then the results of intestinal flora data were analyzed to investigate the effect of Shengmai Jianghuang San on tumors. The results showed that Shengmai Jianghuang San combined with irradiation could enhance the therapeutic effect of tumor treatment. Radiation therapy would reduce the total number and diversity of intestinal flora in nude mice, and also change the structure of the flora. Shengmai Jianghuang San could protect the diversity of colonies, and also partially restore the colony imbalance caused by irradiation. This study provides a research idea for Shengmai Jianghuang San as a sensitizing adjuvant for radiotherapy of nasopharyngeal carcinoma.

摘要

现代药理学研究表明,生脉散具有增强免疫力和改善血液循环的作用,姜黄具有抗炎、抗癌、抗氧化等功能。生脉散联合姜黄是中药抗肿瘤研究的一个新方向。鼻咽癌的主要治疗方法是放射治疗,但放射治疗会引起多种副作用,还会改变肠道菌群的组成。在本研究中,利用16s rDNA测序平台对荷生脉姜黄散静脉瘤裸鼠的肠道菌群样本进行宏测序,然后分析肠道菌群数据结果,以研究生脉姜黄散对肿瘤的影响。结果表明,生脉姜黄散联合照射可增强肿瘤治疗的疗效。放射治疗会减少裸鼠肠道菌群的总数和多样性,也会改变菌群结构。生脉姜黄散可以保护菌落的多样性,还能部分恢复由照射引起的菌落失衡。本研究为生脉姜黄散作为鼻咽癌放疗增敏佐剂提供了研究思路。

相似文献

1
[Effects of Shengmai Jianghuang San on intestinal flora in nude mice with radio resistant cells of nasopharyngeal carcinoma].[生脉姜黄散对鼻咽癌放射抗拒细胞裸鼠肠道菌群的影响]
Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(3):553-558. doi: 10.19540/j.cnki.cjcmm.20181203.001.
2
Integrating serum metabolomics analysis and network pharmacology to reveal the potential mechanism of Shengmai Jianghuang San in the treatment of nasopharyngeal carcinoma.整合血清代谢组学分析与网络药理学以揭示生脉姜黄散治疗鼻咽癌的潜在机制。
Biomed Chromatogr. 2024 Oct;38(10):e5981. doi: 10.1002/bmc.5981. Epub 2024 Aug 7.
3
Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats.中药生脉散对大鼠脑缺血再灌注损伤的预防与修复作用
Free Radic Res. 1999 Nov;31(5):449-55. doi: 10.1080/10715769900301011.
4
An integrated fecal microbiome and metabolome in the aged mice reveal anti-aging effects from the intestines and biochemical mechanism of FuFang zhenshu TiaoZhi(FTZ).肠道微生物群和代谢组学在老年小鼠中的综合分析揭示了复方贞术调脂方(FTZ)的抗衰老作用及其生化机制。
Biomed Pharmacother. 2020 Jan;121:109421. doi: 10.1016/j.biopha.2019.109421. Epub 2019 Nov 25.
5
Regulation of Shaoyao Ruangan Mixture on Intestinal Flora in Mice With Primary Liver Cancer.芍药软肝合剂对肝癌小鼠肠道菌群的调节作用。
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419843178. doi: 10.1177/1534735419843178.
6
[Incompatible mechanism of compatibility of Chinese medicines based on Qianjinzi and Gancao effect on intestinal flora/barrier system].基于千金子与甘草对肠道菌群/屏障系统的作用探讨中药配伍的“相反”机制
Zhongguo Zhong Yao Za Zhi. 2018 Jan;43(2):369-371. doi: 10.19540/j.cnki.cjcmm.20171027.021.
7
Synergistic effect of combination topotecan and chronomodulated radiation therapy on xenografted human nasopharyngeal carcinoma.联合拓扑替康和时间调节放射治疗对人鼻咽癌异种移植瘤的协同作用。
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):356-62. doi: 10.1016/j.ijrobp.2013.05.047. Epub 2013 Jul 29.
8
Study on the protective effect of shengmai san (see text) on the myocardium in the type 2 diabetic cardiomyopathy model rat.生脉散(见正文)对 2 型糖尿病心肌病模型大鼠心肌的保护作用研究。
J Tradit Chin Med. 2011 Sep;31(3):209-19. doi: 10.1016/s0254-6272(11)60044-7.
9
[Research on standard decoction of processed Curcumae Longae Rhizoma containing volatile oil].[含挥发油的炮制后郁金标准汤剂研究]
Zhongguo Zhong Yao Za Zhi. 2018 Mar;43(5):879-884. doi: 10.19540/j.cnki.cjcmm.20180105.013.
10
Shengmai San, a Chinese herbal medicine protects against rat heat stroke by reducing inflammatory cytokines and nitric oxide formation.生脉散,一种中药,通过减少炎性细胞因子和一氧化氮的形成来预防大鼠中暑。
J Pharmacol Sci. 2005 May;98(1):1-7. doi: 10.1254/jphs.fp0050018. Epub 2005 May 7.

引用本文的文献

1
Mechanisms of action of intestinal microorganisms and advances in head and neck tumors.肠道微生物的作用机制与头颈部肿瘤研究进展
Discov Oncol. 2025 Mar 12;16(1):303. doi: 10.1007/s12672-025-02035-y.
2
Global research trends on the links between gut microbiota and radiotherapy: a bibliometric analysis (2004-2023).全球关于肠道微生物群与放射治疗之间关联的研究趋势:文献计量分析(2004-2023 年)。
Front Cell Infect Microbiol. 2024 Sep 4;14:1414196. doi: 10.3389/fcimb.2024.1414196. eCollection 2024.
3
New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer.
肠道微生物群与癌症放射治疗关系的新见解。
Nutrients. 2022 Dec 22;15(1):48. doi: 10.3390/nu15010048.
4
An Active Fraction of Promotes the Regeneration of Intestinal Epithelial Cells After Irradiation.一种活性成分促进辐射后肠上皮细胞的再生。
Front Cell Dev Biol. 2021 Nov 2;9:745412. doi: 10.3389/fcell.2021.745412. eCollection 2021.